The synergistic antitumor activity of 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) and anti-PD-L1 antibody inducing immunogenic cell death

• Main Authors: Xiao-Chuan Duan (Author), Li-Yuan Peng (Author), Xin Yao (Author), Mei-Qi Xu (Author), Hui Li (Author), Shuai-Qiang Zhang (Author), Zhuo-Yue Li (Author), Jing-Ru Wang (Author), Zhen-Han Feng (Author), Guang-Xue Wang (Author), Ai Liao (Author), Ying Chen (Author), Xuan Zhang (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Cancer immunotherapy is a strategy that is moving to the frontier of cancer treatment in the current decade. In this study, we show evidence that 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs), act as immunogenic cell death (ICD) inducers, stimulating an antitumor response...